Related Experiment Videos
Rapid screening of metabolic diseases by proton NMR
Lancet (London, England)
|November 24, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Estimating willingness-to-pay for a livestock vaccine among the marginalized: The role of reflective thought in discrete choice experiments.
Preventive veterinary medicine·2022
Psychosocial predictors of failure to return to work in non-chronic non-specific low back pain: a systematic review.
Occupational and environmental medicine·2008
Nuclear magnetic resonance spectroscopy and genetic disorders.
Current medicinal chemistry·2008
Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.
Journal of inherited metabolic disease·2006
Methylmalonic aciduria: follow-up and enzymology on the original case after 36 years.
Journal of inherited metabolic disease·2006
L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study.
Journal of inherited metabolic disease·2005
Wildfire smoke and health: current evidence, mechanisms, and future challenges.
Lancet (London, England)·2026
Latent Classes of Inflammation-Nutrition-Metabolism Status in Maintenance Hemodialysis: Associations with Arteriovenous Fistula Function and Cardiovascular Prognosis.
Journal of multidisciplinary healthcare·2026
Transhepatic Gradients Reveal Selective Hepatic Processing Defects With Systemic Consequences in Cirrhosis.
Comprehensive physiology·2026
Integrated metabolomic and gut microbiota analyses reveal TCA cycle dysfunction in broiler skeletal disorders and the protective effect of L‑malic acid.
Journal of animal science and biotechnology·2026
Integrated metabolomics and DNA methylation signatures and their association with flare remission in SLE.
Lupus science & medicine·2026
Immune metabolic reprogramming in MASLD.
JHEP reports : innovation in hepatology·2026
Macrophage HDAC3 drives obesity and adipose tissue metabolic maladaptation through GDF3-mediated inflammation and chromatin remodeling.
International immunopharmacology·2026